- $88.2 BnWorld market, 2023
- $192.2 BnProjected, 2033
- 8.1%Growth a year (CAGR)
- 2,392Active clinical trials worldwide
Largest countries
Market size in 2023 · growth a year to 2033
-
1
US
$37 Bn
6.1% a year · 42% of the world -
2
China
$7.1 Bn
9.6% a year · 8% of the world -
3
Canada
$7.1 Bn
8.1% a year · 8% of the world -
4
Japan
$5.5 Bn
8.6% a year · 6.2% of the world -
5
Germany
$3.2 Bn
6.3% a year · 3.7% of the world -
6
France
$2.4 Bn
7.1% a year · 2.8% of the world -
7
UK
$2.3 Bn
6.1% a year · 2.6% of the world -
8
Brazil
$2.2 Bn
9.1% a year · 2.5% of the world -
9
Italy
$2.1 Bn
7.6% a year · 2.4% of the world -
10
Ecuador
$1.8 Bn
8.7% a year · 2% of the world
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)Anti-Aging by country and region
| Place | 2023 | 2033 (projected) | CAGR | World share | Active trials | Report |
|---|---|---|---|---|---|---|
| World | $88.2 Bn | $192.2 Bn | 8.1% | – | 2,392 | Report on Anti-Aging in Global |
| North America | $44.1 Bn | $87.6 Bn | 7.1% | 50% | 1,129 | Report on Anti-Aging in North America |
| APAC | $18.5 Bn | $45.4 Bn | 9.4% | 21% | 262 | Report on Anti-Aging in APAC |
| Europe | $16.8 Bn | $32.5 Bn | 6.8% | 19% | 400 | Report on Anti-Aging in Europe |
| Latin America | $4 Bn | $9.5 Bn | 9.1% | 4.5% | 51 | Report on Anti-Aging in Latin America |
| Middle East | $3.5 Bn | $8.4 Bn | 9.1% | 4% | 1 | Report on Anti-Aging in Middle East |
| Africa | $1.3 Bn | $3.3 Bn | 9.6% | 1.5% | 15 | Report on Anti-Aging in Africa |
| US |
$37 Bn | $67 Bn | 6.1% | 42% | 1,028 | Report on Anti-Aging in US |
| China |
$7.1 Bn | $17.7 Bn | 9.6% | 8% | 146 | Report on Anti-Aging in China |
| Canada |
$7.1 Bn | $15.4 Bn | 8.1% | 8% | 125 | Report on Anti-Aging in Canada |
| Japan |
$5.5 Bn | $12.5 Bn | 8.6% | 6.2% | 20 | Report on Anti-Aging in Japan |
| Germany |
$3.2 Bn | $5.9 Bn | 6.3% | 3.7% | 36 | Report on Anti-Aging in Germany |
| France |
$2.4 Bn | $4.8 Bn | 7.1% | 2.8% | 151 | Report on Anti-Aging in France |
| UK |
$2.3 Bn | $4.1 Bn | 6.1% | 2.6% | 75 | Report on Anti-Aging in UK |
| Brazil |
$2.2 Bn | $5.3 Bn | 9.1% | 2.5% | 36 | Report on Anti-Aging in Brazil |
| Italy |
$2.1 Bn | $4.4 Bn | 7.6% | 2.4% | 96 | Report on Anti-Aging in Italy |
| Ecuador |
$1.8 Bn | $4.1 Bn | 8.7% | 2% | 1 | Report on Anti-Aging in Ecuador |
 Spain |
$1.7 Bn | $3.4 Bn | 7.1% | 1.9% | 115 | Report on Anti-Aging in Spain |
 India |
$1.6 Bn | $4.6 Bn | 11.1% | 1.8% | 9 | Report on Anti-Aging in India |
 Saudi Arabia |
$1.5 Bn | $3.7 Bn | 9.6% | 1.7% | 1 | Report on Anti-Aging in Saudi Arabia |
 Mexico |
$1.3 Bn | $3 Bn | 8.4% | 1.5% | 17 | Report on Anti-Aging in Mexico |
 Australia |
$1.1 Bn | $2.6 Bn | 9.6% | 1.2% | 25 | Report on Anti-Aging in Australia |
 South Africa |
$573 Mn | $1.4 Bn | 9.3% | 0.7% | 2 | Report on Anti-Aging in South Africa |
 UAE |
$441 Mn | $1.1 Bn | 9.1% | 0.5% | 0 | Report on Anti-Aging in UAE |
 Egypt |
$247 Mn | $618 Mn | 9.6% | 0.3% | 13 | Report on Anti-Aging in Egypt |
 Philippines |
$194 Mn | $443 Mn | 8.6% | 0.2% | 1 | Report on Anti-Aging in Philippines |
 Malaysia |
$142 Mn | $315 Mn | 8.3% | 0.2% | 7 | Report on Anti-Aging in Malaysia |
 Hong Kong |
$141 Mn | $338 Mn | 9.1% | 0.2% | 36 | Report on Anti-Aging in Hong Kong |
 Singapore |
$106 Mn | $244 Mn | 8.7% | 0.1% | 43 | Report on Anti-Aging in Singapore |
 Thailand |
$106 Mn | $238 Mn | 8.4% | 0.1% | 8 | Report on Anti-Aging in Thailand |
 Kenya |
$62 Mn | $149 Mn | 9.2% | 0.1% | 0 | Report on Anti-Aging in Kenya |
 New Zealand |
– | – | – | – | 4 | Report on Anti-Aging in New Zealand |
 Russia |
– | – | – | – | 3 | Report on Anti-Aging in Russia |
"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 34,039 papers since 2021
- Dot1 triggers a conserved ribophagy signal to govern ribosome quality and longevity by methylating Rpl12. Molecular cell, 2026
- Senescence-targeted engineered CAR-T immunotherapy: advances, challenges and perspectives for engineered senolytic immunotherapy. EBioMedicine, 2026
- Machine Learning-Based Biomechanical and Clinical Assessment of the Five Times Chair Rise Test in Older Adults: Sensor-Based Functional Aging Study. JMIR aging, 2026
- JUND-DNAJB1-p21 axis drives fibroblast senescence to recruit CD4⁺ T cells in salivary gland pathogenesis of Sjögren's disease. Immunity & ageing : I & A, 2026
- Clinical Evaluation of Apple-Derived Exosome After Microneedling for Facial Rejuvenation: A Prospective Split-Face Self-Controlled Study. Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 2026
Compare Anti-Aging side by side
Key companies in Anti-Aging
Procter & Gamble
Shiseido
Revlon
Unilever
Galderma
Quick answers
How big is the Anti-Aging market?
The world Anti-Aging market was worth about $88.2 Bn in 2023 and is projected to reach $192.2 Bn by 2033, growing 8.1% a year (CAGR).
Which country has the largest Anti-Aging market?
The US is the largest of the 24 countries we cover, at $37 Bn in 2023. India grows fastest, at 11.1% a year.
How many clinical trials are running in Anti-Aging?
ClinicalTrials.gov lists 2,392 active trials worldwide (recruiting, about to start or running), most of them in the US, as of 10 Nov 2026.
How much research is published on Anti-Aging?
PubMed lists about 34,039 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.